Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 inVentiv, Aprecia Enter Commercialization Pact | Contract Pharma

What are you searching for?

Sign in
Breaking News

inVentiv, Aprecia Enter Commercialization Pact

inVentiv to launch Aprecia brand and technology platform

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

inVentiv Health and Aprecia Pharmaceuticals entered an exclusive commercialization alliance for the launch the Aprecia brand and technology platform and initial pharmaceutical products.
 
Aprecia offers the ZipDose product platform using three-dimensional printing (3DP) technology to create fast-melt products. The company has completed clinical development and expects to file its first NDA with the FDA in 2H14. inVentiv will serve as Aprecia’s exclusive provider of commercialization services in exchange for future royalties on sales.
 
“Getting medicine into the human body reliably and accurately is both a challenge and an enormous opportunity,” said Don Wetherhold, chief executive officer of Aprecia. “To realize the potential of our technology and move quickly into market, we sought a partner that could execute every phase and function in commercialization, and inVentiv was the obvious choice.”
  
Michael Griffith, executive vice president of inVentiv Health, said, “We are pleased to have entered into this agreement with Aprecia and are looking forward to introducing their innovative technology platform and their much-needed products. Because of our unmatched expertise of pharmaceutical launches, clients know they can count on inVentiv Health to transform their assets into commercial success.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics